Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Floxuridine”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Testing effectiveness (Phase 2)Looking for participantsNCT07764497
What this trial is testing

Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverLiver Metastasis Colon CancerLiver Metastases From Colorectal Cancer+1 more
Sunnybrook Health Sciences Centre 200
Testing effectiveness (Phase 2)Study completedNCT00063960
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 94
Testing effectiveness (Phase 2)Study completedNCT00004142
What this trial is testing

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00848783
What this trial is testing

Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers

Who this might be right for
Gastric CancerGastric AdenocarcinomaEsophageal Cancer
NYU Langone Health 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT01815359
What this trial is testing

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

Who this might be right for
Appendix CancerColorectal Cancer
Memorial Sloan Kettering Cancer Center 292
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Testing effectiveness (Phase 2)WithdrawnNCT03069950
What this trial is testing

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00587067
What this trial is testing

A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy

Who this might be right for
Hepatic Cancer
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00200200
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Who this might be right for
Hepatic MetastasesColon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 73
Testing effectiveness (Phase 2)Study completedNCT03493061
What this trial is testing

Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

Who this might be right for
Colo-rectal CancerLiver Metastases
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06313203
What this trial is testing

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

Who this might be right for
Intrahepatic CholangiocarcinomaChemotherapy Effect
Oslo University Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)UnknownNCT05865925
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Luye Pharma Group Ltd. 78
Early research (Phase 1)Study completedNCT00001449
What this trial is testing

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00008294
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002842
What this trial is testing

Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
City of Hope Medical Center 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04898504
What this trial is testing

HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.

Who this might be right for
Colorectal CancerLiver MetastasesChemotherapy Effect
Oslo University Hospital 45
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04251715
What this trial is testing

MFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver and Intrahepatic Bile Duct CarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8+3 more
OHSU Knight Cancer Institute 5
Early research (Phase 1)Study completedNCT00001576
What this trial is testing

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Who this might be right for
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 28
Next Page